Sepsis & infection

Endothelial glycocalyx degradation and its association with clinical outcomes and host response aberrations in community-acquired pneumonia across different care settings

Crit CarePublished Observational cohort study

Authors' conclusion

Glycocalyx degradation, as measured by plasma syndecan-1, shows a non-linear association with mortality in patients with CAP. Key systemic host response changes implicated in sepsis pathogenesis occur prior to detectable glycocalyx degradation in this population.

Study context

Population
Patients with community-acquired pneumonia (CAP) on presentation in emergency department (ED), general ward or intensive care unit (ICU)
Participants
384 CAP patients
Exposure
Elevated-Syndecan-1 vs Normal-Syndecan-1
  • Non-infectious controlsn = 50
Outcome
Mortality / survival
Follow-up
30 days
Methodological detailsmultiple care settings (ED, general ward, ICU), blood transcriptomics, Samples from 95 in the ED, 124 after general ward admission, 165 after ICU admission
  • Multiple care settings (ED, general ward, ICU)
  • Blood transcriptomics
  • Samples from 95 in the ED, 124 after general ward admission, 165 after ICU admission

Main finding

As reported in the abstract

30-day survival
  • Relationship between syndecan-1 (continuous) and 30-day mortality non-linear and independent of comorbidities and disease severity
  • Elevated-Syndecan-1 vs Normal-Syndecan-1: P < 0.05

Observational data: associations, not effects.

Further findings

Host response biomarkers (32 biomarkers, five domains)

Most biomarkers already strongly elevated in Normal-Syndecan-1 vs non-infectious controls, across all domains
All biomarkers further increased in Elevated-Syndecan-1, also in direct comparison with Normal-Syndecan-1

Blood leukocyte transcriptome (gene set enrichment analysis)

Elevated syndecan-1 linked to increased expression of genes for extracellular matrix organization and hemostasis

Original publication

Endothelial glycocalyx degradation and its association with clinical outcomes and host response aberrations in community-acquired pneumonia across different care settings. Crit Care. Published 27 January 2026. doi:10.1186/s13054-025-05719-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.